Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Acetaminophen versus acetaminophen plus caffeine for electroconvulsive therapy-induced headache
IRCT20170207032435N3Phase 3Completed
- Sponsor
- Tehran University of Medical Sciences
- Start
- Jun 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, single-blind trial of acetaminophen and caffeine in Headache (2 arms), sponsored by Tehran University of Medical Sciences. Primary endpoint: Headache intensity. Started Jun 2017; status: completed.
02
Drugs
acetaminophencaffeine
03
Conditions
Headache
Beyond the preview
Go deeper on IRCT20170207032435N3.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20170207032435N3.